At AAO 2026, Anjum F. Koreishi, MD, shared how to prevent complications after cataract surgery in patients with uveitis.

David F. Chang, MD, shares how to set realistic refractive IOL expectations and streamline patient counseling.

Timothy Janetos, MD, explained when to refer uveitis to a specialist and why access to uveitis care remains limited.

Taken together, these three responses point to gaps beyond the next therapy: in how academic medicine is valued, in what ...

The FDA has approved Enspryng (satralizumab, Genentech) for thyroid eye disease (TED), making the drug the first subcutaneous ...

At AAO 2026, Adam, MD, shares Yamane technique pearls, from docking the trailing haptic to preventing tilt and haptic ...

In addition to the results, Roche also announced that the US Food and Drug Administration (FDA) has accepted the company’s ...

Jacque Duncan, MD, reviews phase 3 DRAGON data on oral tinlarebant for Stargardt disease and its mechanism-related visual ...

Ryzumvi (phentolamine ophthalmic solution 0.75%) is approved for the treatment of presbyopia in adults. It is also approved for pharmacologically induced mydriasis produced by adrenergic agonists or ...

David F. Chang, MD, explained how offering complementary refractive IOLs reduces patient anxiety and indecision.

Alvotech and Advanz Pharma have submitted a European regulatory application for AVT29, a proposed biosimilar to high-dose ...

Restoring sight after whole human eye transplant remains a long-term goal, and the optic nerve is the limiting factor, ...